Recordati Industria Chimica e Farmaceutica S.p.A. Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| AZN | AstraZeneca PLC | Outperform |
17
|
£121.10 | Buy/Sell | £165.99 | 34.64% | 16 | £187.73B |
| ABT | Abbott Laboratories | Outperform |
9
|
$104.09 | Buy/Sell | $118.92 | 21.53% | 7 | $181.08B |
| PFE | Pfizer | Outperform |
2
|
$28.64 | Buy/Sell | $32.87 | 6.49% | 6 | $162.29B |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.13k | Buy/Sell | ¥4.74k | 8.96% | 0 | ¥6.48T |
| ARGX | argenx | Outperform |
4
|
339.90€ | Buy/Sell | 531.81€ | 28.39% | 10 | 20.20€B |
| GMAB | Genmab A/S | Outperform |
16
|
kr2.04k | Buy/Sell | kr2.71k | 29.35% | 14 | kr131.83B |
| VTRS | Viatris Inc | Hold |
8
|
$10.98 | Buy/Sell | $11.73 | 9.29% | 5 | $13.32B |
| IPN | Ipsen | Outperform |
17
|
120.80€ | Buy/Sell | 127.95€ | -0.66% | 0 | 9.88€B |
| CHDN | Churchill Downs | Buy |
16
|
$133.62 | Buy/Sell | $143.67 | 8.52% | 2 | $10.17B |
| ZEAL | Zealand Pharma A/S | Outperform |
8
|
kr600.00 | Buy/Sell | kr357.00 | 35.83% | 2 | kr38.52B |
| HIK | Hikma Pharmaceuticals PLC | Outperform |
18
|
£19.78 | Buy/Sell | £28.11 | 47.67% | 9 | £4.42B |
| ORNBV | Orion Oyj | Hold |
14
|
37.69€ | Buy/Sell | 42.52€ | 11.44% | 3 | 5.12€B |
| ALK B | ALK-Abelló A/S | Outperform |
13
|
kr152.00 | Buy/Sell | kr109.25 | 8.55% | 3 | kr33.91B |
| ALRM | Alarm.com Holdings | Outperform |
16
|
$69.04 | Buy/Sell | $67.13 | 21.67% | 7 | $3.45B |
| VIRP | Virbac | Outperform |
18
|
354.50€ | Buy/Sell | 348.34€ | 5.78% | 5 | 2.98€B |
| MOR | MorphoSys | Hold |
6
|
69.35€ | Buy/Sell | 28.78€ | -1.95% | 3 | 2.52€B |
| CORT | Corcept Therapeutics | Buy |
16
|
$28.09 | Buy/Sell | $35.67 | 42.40% | 4 | $2.55B |
| BHC | Bausch Health Companies | Hold |
15
|
$6.77 | Buy/Sell | $9.50 | 40.32% | 5 | $2.55B |
| INDV | Indivior PLC | Buy |
14
|
£13.37 | Buy/Sell | £28.89 | 131.34% | 4 | £1.95B |
| PENN | PENN Entertainment | Outperform |
13
|
$15.93 | Buy/Sell | $29.89 | 31.83% | 1 | $2.29B |
| ALM | Almirall | Outperform |
16
|
9.27€ | Buy/Sell | 11.39€ | 18.66% | 3 | 1.94€B |
| EVT | Evotec | Outperform |
14
|
9.76€ | Buy/Sell | 37.33€ | 74.18% | 4 | 1.73€B |
| COPN | Cosmo Pharmaceuticals N.V. | Buy |
12
|
CHF72.90 | Buy/Sell | CHF76.55 | 28.34% | 0 | CHF1.14B |
| FAE | Faes Farma | Hold |
18
|
3.66€ | Buy/Sell | 3.90€ | -0.27% | 0 | 1.09€B |
| MERC | Mercer International | Hold |
14
|
$10.18 | Buy/Sell | $8.63 | 5.60% | 4 | $722.06M |
| PHM | Pharma Mar | Outperform |
13
|
36.72€ | Buy/Sell | 50.20€ | 30.72% | 1 | 536.95€M |
| BSLN | Basilea Pharmaceutica | Outperform |
6
|
CHF43.65 | Buy/Sell | CHF65.63 | 51.20% | 0 | CHF529.94M |
| SFA | Sopharma AD | Buy |
14
|
лв6.08 | Buy/Sell | лв6.96 | 17.43% | 0 | лв997.04M |
| XERS | Xeris Biopharma Holdings | Buy |
6
|
$1.98 | Buy/Sell | $4.60 | 152.53% | 1 | $260.93M |
| DBV | DBV Technologies | Outperform |
5
|
1.27€ | Buy/Sell | 4.07€ | 214.96% | 1 | 115.65€M |
| MOLN | Molecular Partners | Outperform |
4
|
CHF3.31 | Buy/Sell | CHF9.50 | 182.48% | 1 | CHF110.77M |